The median age at symptom onset in the cohort was 55 years, ranging from 16 to 81 years. Data from patients’ initial ...

To more effectively treat neurodegenerative conditions, we first need diagnostic tools that lend a more complete picture of ...

A study by the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB) reveals that inflammation ...

A study reveals that inflammation associated with Marfan syndrome increases vulnerability to neurological diseases and complications following strokes, as demonstrated in animal models.

The United States on Friday approved the first blood test for Alzheimer's, a move that could help patients begin treatment ...

Discover the differences between Parkinson's disease and similar movement disorders that mimic its symptoms, from essential ...

Sage Therapeutics Inc. leadership overhyped prospects for three neurological and psychiatric treatments, harming the biopharmaceutical company’s repute and wallet, a shareholder lawsuit said.

Stroke, a leading cause of premature death and disability, is on the rise due to demographic shifts and lifestyle-related ...

Integrating a blood-based biomarker assay into clinical workflows can enhance decision-making in patients with multiple ...

BrainProbe won gold in the Advancements in Neurological Treatments category at the 2025 Edison Awards, an event established in 1987 that honors “excellence in new product and service development ...

The goal is to reuse key parts of the treatment and simply swap in a custom set of instructions for each patient's specific ...